Literature DB >> 11804288

Synthesis and characterization of novel water soluble amphotericin B-arabinogalactan conjugates.

T Ehrenfreund-Kleinman1, T Azzam, R Falk, I Polacheck, J Golenser, A J Domb.   

Abstract

The coupling of amphotericin B (AmB), a water-insoluble antifungal agent, to arabinogalactan (AG) via an imine or amine bond was systematically investigated. AG was oxidized using potassium periodate, purified from the oxidizing agent using ion-exchange chromatography, and reacted with AmB to form the Schiff base. The Schiff base was reduced to the amine using borohydride. All reactions took place in aqueous media. The purification of the oxidized AG from the oxidizing agent was essential to prevent oxidative degradation of AmB at the coupling step. We investigated the effects of AmB to AG ratio, buffer type, and reaction pH on the reaction yield, molecular weight, conjugate activity against pathogenic yeast and hemolytic activity. The optimum coupling conditions were buffer borate 0.1 M, pH 11 at room temperature for 48 h. Lower toxicity in vivo was achieved by using low-pressure gel permeation chromatography and applying the solution of AmB-AG conjugate through a Sephadex column. Both amine and imine AmB-AG conjugates were soluble in water and exhibited improved stability in aqueous solutions as compared to the unbound drug. The conjugates showed comparable minimum inhibitory concentration (MIC) values against Candida albicans. The conjugates were about 60 times less hemolytic against sheep erythrocytes than the free drug, and about 40 times less toxic in BALB/c mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11804288     DOI: 10.1016/s0142-9612(01)00251-4

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  Distribution of amphotericin B-arabinogalactan conjugate in mouse tissue and its therapeutic efficacy against murine aspergillosis.

Authors:  Rama Falk; Jacob Grunwald; Amnon Hoffman; Abraham J Domb; Itzhack Polacheck
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

2.  Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactan.

Authors:  Sarah Kagan; Diana Ickowicz; Miriam Shmuel; Yoram Altschuler; Edward Sionov; Miriam Pitusi; Aryeh Weiss; Shimon Farber; Abraham J Domb; Itzhack Polacheck
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

3.  Amphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against Leishmania and fungi.

Authors:  K K Nishi; M Antony; P V Mohanan; T V Anilkumar; P M Loiseau; A Jayakrishnan
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580

4.  Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.

Authors:  Qamar Zia; Aijaz Ahmed Khan; Zubair Swaleha; Mohammad Owais
Journal:  Int J Nanomedicine       Date:  2015-03-05

5.  Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals.

Authors:  Qamar Zia; Owais Mohammad; Mohd Ahmar Rauf; Wasi Khan; Swaleha Zubair
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379

Review 6.  Optimizing efficacy of Amphotericin B through nanomodification.

Authors:  Gillian Barratt; Stéphane Bretagne
Journal:  Int J Nanomedicine       Date:  2007

7.  Engineered biosynthesis of disaccharide-modified polyene macrolides.

Authors:  Eimear De Poire; Niamh Stephens; Bernard Rawlings; Patrick Caffrey
Journal:  Appl Environ Microbiol       Date:  2013-08-02       Impact factor: 4.792

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.